John Hopkins Webinar on transplant recipients and vaccines

Interesting read:
Call in the T-Cell Cavalry to Fight COVID in the Immunocompromised
— Preliminary research suggests immunotherapy could play role in protecting vaccine non-responders
by Catherine Bollard, MD, MBChB July 29, 2021
https://www.medpagetoday.com/opinion/second-opinions/93805?xid=nl_secondopinion_2021-08-01&eun=g1900985d0r

Great information @athenalee! (as always!!) Have you also seen some of the discussions about Regeneron and immune suppressed patients?Possibly getting an infusion proactively. It's another potential solution in addition to the T cell immunotherapy possibility. I am thrilled that the medical and pharmaceutical community are highly aware of our challenge and fully engaged looking for an effective strategy! I know you are an avid reader of the medical and science journals so please continue to forward all the studies and clinical trials you discover! It is very much appreciated and gives me great hope that an answer will be found.

Thank you. Knowledge is a good thing…albeit depressing sometimes! Yes, I do hope for something that’ll help us build some protection against Covid. But, I’m still skeptical given the nature of our meds and also for those of us who have autoimmune diseases. As much as I don’t like wearing a mask, I think I’ll be one to continue doing so inside anyway.

New upcoming webinar:
In conjunction with the COVID-19 Antibody Testing of Recipients of Solid Organ Transplants (IRB00248540) being led by the transplant team at Johns Hopkins.

The National Kidney Foundation is hosting a Patient Education webinar this Sunday, September 19, 2021 from 1:30pm – 3:30 pm Pacific Time. Two physicians from our study team, Dr. Jonathan Mitchell and Dr. Robin Avery, will be guest speakers.

If you would like to attend this webinar, you can register by going to: https://sforce.co/3lSdzTG

I was not available to attend this webinar. Did anyone attend? Are there any future seminars planned?

What is something helpful/hopeful that you learned while listening to the John Hopkins physicians education seminar - COVID-19 Antibody Testing of Recipients of Solid Organ Transplants?

I know the John Hopkins study is ongoing, however, I’ve not seen notice of any new findings or webinars, since the July 8 webinar.

New John Hopkins webinar-

We plan to broadcast a 1-hour live webinar on Wednesday, February 23, 2022, at 1:00PM EST for our study participants. The purpose of the webinar is to share our updated findings from the Observational Study with you and answer some of your questions. The purpose of the webinar is not to provide medical advice regarding vaccines, COVID-19 treatments, or answer any other medical questions. If you are unable to view the live webcast, do not worry. The webcast will be recorded, and we will share a link of the recording with everyone in the research study as we have in the past.

The video hosting platform for this webinar will be on Microsoft Teams. You do not need a Teams account to log on (you may as a Guest), or you can use your personal Teams account if you already have one.

Please register here: https://teams.microsoft.com/registration/OPSkn-axO0eAP4b4rt8N7A,lFYj96kbT0idwVD3528Jmw,MAXcs6AtbEK6f5GJsSr1IQ,48uruCPpSU6p05ZUWKnhyw,aphrKncNXkyzVXDMfNQefA,zNlvMUtjjUmWPn-T0bg3lQ?mode=read&tenantId=9fa4f438-b1e6-473b-803f-86f8aedf0dec

You will receive an email with a link to click to join the webinar shortly after registering. On the day of the webinar, simply click that link to join. If you are not logged in to a Teams account, you will be prompted to enter your name. Please note that your name will be displayed for other study participants to see. If you would like to remain anonymous, please enter “anonymous” as your name.

Only the first 1,000 participants will be able to use the chat feature for the webinar. That means that if we exceed 1,000 viewers, person 1,001 and beyond will be able to watch, but not chat. This is a software limitation and out of our control.

We will answer some of our most frequently asked questions related to our research and have a panel discussion with experts from Johns Hopkins. If you would like to submit a question ahead of time, you may do so when you complete the registration form. We have received hundreds of questions in the past, and so cannot guarantee that every question will be answered, but we will do our best.

We would like to reiterate our thanks to you for participating in this study, and we look forward to seeing you and sharing our updates with you on February 23rd.

Respectfully,

Jennifer Alejo, MD

William Werbel, MD

Dorry Segev, MD PhD

Jacqueline Garonzik-Wang, MD PhD

Robin Avery, MD

Thanks for sharing.